ras oncogenes in human cancer: a review
- PMID: 2547513
ras oncogenes in human cancer: a review
Erratum in
- Cancer Res 1990 Feb 15;50(4):1352
Abstract
Mutations in codon 12, 13, or 61 of one of the three ras genes, H-ras, K-ras, and N-ras, convert these genes into active oncogenes. Rapid assays for the detection of these point mutations have been developed recently and used to investigate the role mutated ras genes play in the pathogenesis of human tumors. It appeared that ras gene mutations can be found in a variety of tumor types, although the incidence varies greatly. The highest incidences are found in adenocarcinomas of the pancreas (90%), the colon (50%), and the lung (30%); in thyroid tumors (50%); and in myeloid leukemia (30%). For some tumor types a relationship may exist between the presence of a ras mutation and clinical or histopathological features of the tumor. There is some evidence that environmental agents may be involved in the induction of the mutations.
Similar articles
-
Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.Clin Cancer Res. 1995 Mar;1(3):359-65. Clin Cancer Res. 1995. PMID: 9815992
-
The ras gene family in human non-small-cell lung cancer.J Natl Cancer Inst Monogr. 1992;(13):23-9. J Natl Cancer Inst Monogr. 1992. PMID: 1327034
-
Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.Oncogene. 1993 Sep;8(9):2407-12. Oncogene. 1993. PMID: 8395679
-
Occurrence of ras mutations in human lung cancer. Minireview.Neoplasma. 1997;44(3):145-9. Neoplasma. 1997. PMID: 9372854 Review.
-
ras and human tumors.Semin Cancer Biol. 1992 Aug;3(4):241-7. Semin Cancer Biol. 1992. PMID: 1421168 Review.
Cited by
-
Monocarboxylate transporter 1 contributes to growth factor-induced tumor cell migration independent of transporter activity.Oncotarget. 2016 May 31;7(22):32695-706. doi: 10.18632/oncotarget.9016. Oncotarget. 2016. PMID: 27127175 Free PMC article.
-
miR-98 functions as a tumor suppressor in salivary adenoid cystic carcinomas.Onco Targets Ther. 2016 Mar 23;9:1777-86. doi: 10.2147/OTT.S98534. eCollection 2016. Onco Targets Ther. 2016. PMID: 27042128 Free PMC article.
-
KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells.PLoS One. 2012;7(11):e50701. doi: 10.1371/journal.pone.0050701. Epub 2012 Nov 28. PLoS One. 2012. PMID: 23209813 Free PMC article.
-
Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.BMC Cancer. 2021 Jun 8;21(1):677. doi: 10.1186/s12885-021-08427-x. BMC Cancer. 2021. PMID: 34102999 Free PMC article.
-
In TCR-stimulated T-cells, N-ras regulates specific genes and signal transduction pathways.PLoS One. 2013 Jun 3;8(6):e63193. doi: 10.1371/journal.pone.0063193. Print 2014. PLoS One. 2013. PMID: 23755101 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous